DANIEL R. OMSTEAD, ENG.SCD.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

abrdn Healthcare Investors

Filing Date	Source Excerpt
2004-05-24	DANIEL R. OMSTEAD, ENG.SCD.* (50), 30 ROWES WHARF, BOSTON, MA 02110 President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; President and Chief Executive Officer (from 1998-2000) of Reprogenesis, Inc. For the fiscal year ended September 30, 2003, the Independent Trustees as a group received $136,980 from HQH and $134,714 from HQL for fees and reimbursed expenses. The following table sets forth information regarding compensation of Trustees by the Funds for the fiscal year ended September 30, 2003, but does not include expenses. Daniel R. Omstead, Eng.ScD. $0.

Filing Date

Source Excerpt

2004-05-24

abrdn Life Sciences Investors

Filing Date	Source Excerpt
2004-05-24	DANIEL R. OMSTEAD, ENG.SCD.* (50), 30 ROWES WHARF, BOSTON, MA 02110 President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; President and Chief Executive Officer (from 1998-2000) of Reprogenesis, Inc. For the fiscal year ended September 30, 2003, the annual fee was $15,000. Trustees of each Fund are also paid $1,000 for each Board and Committee meeting attended in person and $500 for each Board and Committee meeting attended by telephone. The Chairman of the Board of Trustees of each Fund receives an additional annual fee of $2,500, the Chairman of each Committee receives an additional annual fee of $1,500 and each Committee member receives an additional annual fee of $500. Independent Trustees as a group received $136,980 from HQH and $134,714 from HQL for fees and reimbursed expenses. No other direct compensation has been paid by the Funds to the Trustees and officers as a group. Trustees and officers of the Funds who hold positions with the Adviser receive indirect compensation from the Funds in the form of the investment advisory fee paid to the Adviser. The following table sets forth information regarding compensation of Trustees by the Funds for the fiscal year ended September 30, 2003, but does not include expenses. Daniel R. Omstead, Eng.ScD. $0.

Filing Date

Source Excerpt

2004-05-24

DANIEL R. OMSTEAD, ENG.SCD.* (50), 30 ROWES WHARF, BOSTON, MA 02110 President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; President and Chief Executive Officer (from 1998-2000) of Reprogenesis, Inc. For the fiscal year ended September 30, 2003, the annual fee was $15,000. Trustees of each Fund are also paid $1,000 for each Board and Committee meeting attended in person and $500 for each Board and Committee meeting attended by telephone. The Chairman of the Board of Trustees of each Fund receives an additional annual fee of $2,500, the Chairman of each Committee receives an additional annual fee of $1,500 and each Committee member receives an additional annual fee of $500. Independent Trustees as a group received $136,980 from HQH and $134,714 from HQL for fees and reimbursed expenses. No other direct compensation has been paid by the Funds to the Trustees and officers as a group. Trustees and officers of the Funds who hold positions with the Adviser receive indirect compensation from the Funds in the form of the investment advisory fee paid to the Adviser. The following table sets forth information regarding compensation of Trustees by the Funds for the fiscal year ended September 30, 2003, but does not include expenses. Daniel R. Omstead, Eng.ScD. $0.

Data sourced from SEC filings. Last updated: 2026-02-03